Proposed Medicare cuts could put the squeeze on TAVR

Movement toward same-day discharge for transcatheter aortic valve replacement (TAVR) patients to reduce healthcare costs.

Medicare was the primary payer for 90 percent of transcatheter aortic valve replacement (TAVR) hospitalizations over a recent three-year period, according to a March 19 report in JACC: Cardiovascular Interventions. With that in mind, the recent proposal to cut $473 billion from the CMS budget over the next decade could limit access to the increasingly popular procedure, researchers noted.